Noninvasive Detection of Tuberculosis by Oral Swab Analysis.


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
03 2019
Historique:
received: 20 11 2018
accepted: 05 12 2018
pubmed: 14 12 2018
medline: 29 5 2020
entrez: 14 12 2018
Statut: epublish

Résumé

Diagnostic tests for tuberculosis (TB) usually require collection of sputum, a viscous material derived from human airways. Sputum can be difficult and hazardous to collect and challenging to process in the laboratory. Oral swabs have been proposed as alternative sample types that are noninvasive and easy to collect. This study evaluated the biological feasibility of oral swab analysis (OSA) for the diagnosis of TB. Swabs were tested from South African adult subjects, including sputum GeneXpert MTB/RIF (GeneXpert)-confirmed TB patients (

Identifiants

pubmed: 30541931
pii: JCM.01847-18
doi: 10.1128/JCM.01847-18
pmc: PMC6425180
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R21 AI119473
Pays : United States

Informations de copyright

Copyright © 2019 Luabeya et al.

Références

Sci Transl Med. 2017 Dec 13;9(420):
pubmed: 29237757
Emerg Infect Dis. 2017 Mar;23(3):496-499
pubmed: 28221118
Emerg Microbes Infect. 2012 Oct;1(10):e30
pubmed: 26038402
Appl Environ Microbiol. 2001 Mar;67(3):1225-31
pubmed: 11229914
J Clin Microbiol. 2013 Dec;51(12):4161-6
pubmed: 24108610
J Physiol. 1972 Feb;220(3):529-45
pubmed: 5016036
J Clin Microbiol. 2010 Apr;48(4):1182-8
pubmed: 20107097
Cell Microbiol. 2006 May;8(5):806-14
pubmed: 16611229
Clin Infect Dis. 2013 Aug;57(3):e18-21
pubmed: 23580738
Curr Opin Pulm Med. 2013 May;19(3):280-8
pubmed: 23528956
Appl Environ Microbiol. 2008 Mar;74(6):1798-804
pubmed: 18245256
BMC Infect Dis. 2015 Jan 22;15:24
pubmed: 25608746
Emerg Infect Dis. 2015 Mar;21(3):452-5
pubmed: 25642998
Annu Rev Genomics Hum Genet. 2010;11:427-46
pubmed: 20690815
Cochrane Database Syst Rev. 2016 May 10;(5):CD011420
pubmed: 27163343
Am J Primatol. 2012 Jul;74(7):676-86
pubmed: 22644580
BMC Infect Dis. 2016 Sep 22;16(1):501
pubmed: 27659507
Appl Environ Microbiol. 2006 Dec;72(12):7554-8
pubmed: 17012594
Sci Rep. 2015 Mar 02;5:8668
pubmed: 25727773
Lancet Infect Dis. 2013 Apr;13(4):349-61
pubmed: 23531388
Am J Trop Med Hyg. 2018 Mar;98(3):650-652
pubmed: 29363452
J Microbiol Methods. 2006 Jul;66(1):177-80
pubmed: 16427712
Br Med Bull. 2007;81-82:149-65
pubmed: 17470475
Infect Immun. 2013 Jul;81(7):2645-59
pubmed: 23670556
BMC Infect Dis. 2016 Oct 3;16(1):533
pubmed: 27716170
Lancet Infect Dis. 2012 Mar;12(3):169-70
pubmed: 22015304

Auteurs

Angelique K Luabeya (AK)

South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease & Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.

Rachel C Wood (RC)

Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, Washington, USA.

Justin Shenje (J)

South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease & Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.

Elizabeth Filander (E)

South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease & Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.

Cynthia Ontong (C)

South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease & Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.

Simbarashe Mabwe (S)

South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease & Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.

Hadn Africa (H)

South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease & Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.

Felicia K Nguyen (FK)

Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, Washington, USA.

Alaina Olson (A)

Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, Washington, USA.

Kris M Weigel (KM)

Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, Washington, USA.

Lisa Jones-Engel (L)

Department of Anthropology, University of Washington, Seattle, Washington, USA.

Mark Hatherill (M)

South African Tuberculosis Vaccine Initiative (SATVI), Institute of Infectious Disease & Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.

Gerard A Cangelosi (GA)

Department of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, Washington, USA gcang@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH